DE69717076D1 - Verfahren zur herstellung von galanthanin - Google Patents

Verfahren zur herstellung von galanthanin

Info

Publication number
DE69717076D1
DE69717076D1 DE69717076T DE69717076T DE69717076D1 DE 69717076 D1 DE69717076 D1 DE 69717076D1 DE 69717076 T DE69717076 T DE 69717076T DE 69717076 T DE69717076 T DE 69717076T DE 69717076 D1 DE69717076 D1 DE 69717076D1
Authority
DE
Germany
Prior art keywords
pct
galanthamine
date jul
galanthanine
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69717076T
Other languages
English (en)
Other versions
DE69717076T2 (de
Inventor
David Tiffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69717076D1 publication Critical patent/DE69717076D1/de
Application granted granted Critical
Publication of DE69717076T2 publication Critical patent/DE69717076T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Glass Compositions (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69717076T 1996-01-04 1997-01-06 Verfahren zur herstellung von galanthanin Expired - Lifetime DE69717076T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600080.7A GB9600080D0 (en) 1996-01-04 1996-01-04 Resolution process
PCT/GB1997/000023 WO1997025330A1 (en) 1996-01-04 1997-01-06 Process for the preparation of galanthamine

Publications (2)

Publication Number Publication Date
DE69717076D1 true DE69717076D1 (de) 2002-12-19
DE69717076T2 DE69717076T2 (de) 2003-07-17

Family

ID=10786571

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69717076T Expired - Lifetime DE69717076T2 (de) 1996-01-04 1997-01-06 Verfahren zur herstellung von galanthanin

Country Status (12)

Country Link
US (1) US6087495A (de)
EP (1) EP0880525B1 (de)
AT (1) ATE227725T1 (de)
AU (1) AU700997B2 (de)
CA (1) CA2239814C (de)
DE (1) DE69717076T2 (de)
DK (1) DK0880525T3 (de)
ES (1) ES2186862T3 (de)
GB (1) GB9600080D0 (de)
PT (1) PT880525E (de)
WO (1) WO1997025330A1 (de)
ZA (1) ZA9781B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2310926C (en) * 2000-04-03 2002-10-15 Janssen Pharmaceutica N.V. A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine
WO2006013546A2 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Process for the preparation of pure galantamine
CN102050826B (zh) * 2010-12-21 2012-11-14 浙江工业大学 一种分离加兰他敏的方法
WO2015108634A1 (en) 2014-01-15 2015-07-23 Exxonmobil Chemical Patents Inc. Propylene-based impact copolymers
US11370902B2 (en) 2017-09-11 2022-06-28 Exxonmobil Chemical Patents Inc. Articles comprising polypropylene impact copolymers and methods of making the same
US20230235105A1 (en) 2020-07-17 2023-07-27 Exxonmobil Chemical Patents Inc. Polymers with low levels of volatile organic compounds and methods of making such polymers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
ES2186862T3 (es) 2003-05-16
EP0880525B1 (de) 2002-11-13
AU1386797A (en) 1997-08-01
CA2239814A1 (en) 1997-07-17
DK0880525T3 (da) 2003-03-03
ATE227725T1 (de) 2002-11-15
CA2239814C (en) 2006-08-29
ZA9781B (en) 1998-01-06
WO1997025330A1 (en) 1997-07-17
AU700997B2 (en) 1999-01-14
US6087495A (en) 2000-07-11
EP0880525A1 (de) 1998-12-02
DE69717076T2 (de) 2003-07-17
PT880525E (pt) 2003-03-31
GB9600080D0 (en) 1996-03-06

Similar Documents

Publication Publication Date Title
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
DE69716713D1 (de) Verfahren zur herstellung von d-threo-(r,r)-methylphenidat und recycling nicht erwünschter enantiomere durch epimerisierung
DE69527617D1 (de) Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten
ATE227725T1 (de) Verfahren zur herstellung von galanthanin
ATE216365T1 (de) Verfahren zur racematspaltung
DE59611017D1 (de) Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen
ATE218131T1 (de) Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
SE9601600D0 (sv) Improved process
DE69713163T2 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
ATE258161T1 (de) Verfahren zur herstellung von chiralen aminosäuren
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
ATE268753T1 (de) Verfahren zur herstellung von 24(s)- hydroxyvitamin d2
ATE269863T1 (de) Verfahren zur herstellung von granisetron
DE69510798T2 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure
DE69707639T2 (de) Verfahren zur herstellung einer aktivierten aminosäure
ATE215603T1 (de) Verfahren zur herstellung von optisch aktivem 2- substituiertem tetrahydropyran-4-on
DE69510227T2 (de) Verfahren zur herstellung von fluorierten heterozyklischen verbindungen
DE69514115D1 (de) Verfahren zur herstellung von levobupivacain und analogue aus l-lysin
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition